✦ LIBER ✦

Comparative pharmacokinetic study of high-dose etoposide and etoposide phosphate in patients with lymphoid malignancy receiving autologous stem cell transplantation

✍ Scribed by Dorr, R T; Briggs, A; Kintzel, P; Meyers, R; Chow, H-HS; List, A

Book ID: 110013615
Publisher: Nature Publishing Group
Year: 2003
Tongue: English
Weight: 142 KB
Volume: 31
Category: Article
ISSN: 0007-1188
DOI: 10.1038/sj.bmt.1703906

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High-dose melphalan versus busulfan, cyc

High-dose melphalan versus busulfan, cyclophosphamide, and etoposide as preparative regimens for autologous stem cell transplantation in patients with multiple myeloma

✍ Don M. Benson Jr.; Patrick J. Elder; Thomas S. Lin; William Blum; Sam Penza; Bel 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 192 KB

Phase I study of high-dose thiotepa with

Phase I study of high-dose thiotepa with busulfan, etoposide, and autologous stem cell support in children with disseminated solid tumors

✍ Pession, Andrea; Prete, Arcangelo; Locatelli, Franco; Bella, Santiago; Melchiond 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB 👁 2 views

Background. The aim of this phase I study was to define the maximum tolerated dose (MTD) of thiotepa (TT), administered with busulfan (BU) 480 mg/m 2 and etoposide 2,400 mg/m 2 , followed by autologous bone marrow transplantation (ABMT) or peripheral blood stem cell transplantation (APBSCT) support

High-dose chemotherapy with carboplatin,

High-dose chemotherapy with carboplatin, etoposide and ifosfamide followed by autologous stem cell rescue in patients with relapsed or refractory malignant lymphomas: a phase I/II study

✍ Kleiner, S; Kirsch, A; Schwaner, I; Kingreen, D; Schwella, N; Huhn, D; Siegert, 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 87 KB

Salvage chemotherapy with high-dose carb

Salvage chemotherapy with high-dose carboplatin plus etoposide and autologous peripheral blood stem cell transplant in male pure choriocarcinoma: a retrospective analysis of 13 cases

✍ Papiani, G; Einhorn, L H 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 96 KB

Phase II trial of high-dose intravenous

Phase II trial of high-dose intravenous doxorubicin, etoposide, and cyclophosphamide with autologous stem cell support in patients with residual or responding recurrent ovarian cancer

✍ Morgan, R J; Doroshow, J H; Leong, L; Schriber, J; Shibata, S; Forman, S; Hamasa 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 91 KB

A comparative study of outcomes of idaru

A comparative study of outcomes of idarubicin- and etoposide-intensified conditioning regimens for allogeneic peripheral blood stem cell transplantation in patients with high-risk acute leukemia

✍ Li, Qiu-bai; Li, Lei; You, Yong; Chen, Zhi-chao; Xia, Ling-hui; Zou, Ping 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 Chinese ⚖ 382 KB